Newsletter Subject

Don't Miss this High-Growth Stock 🚨

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Tue, Feb 21, 2023 01:14 PM

Email Preheader Text

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarke

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Tuesday, February 21st. I hope you enjoyed the long weekend. 📢UPDATE ON OUR BIG ANNOUNCEMENT: We've worked out most of the last-minute kinks, and we're almost ready to make our big news public. We sincerely appreciate your patience. Expect the BIG NEWS to drop sometime this week! Let's get ready to trade! Markets 📈 The Dow closed with a 0.3% gain on Friday, while the S&P 500 lost 0.2%. The Nasdaq fell half a point, and the small-cap Russell 2K closed flat. This morning, futures are pointing to more losses at the open. S&P 500 contracts are down 0.7% in early morning trading. Sponsored [Don't Miss this High-Growth Stock 🚨]( This tiny stock could be well positioned in a lucrative market, and the Smart Money is quietly taking notice. Its shares are trading at an absurd 60% discount relative to other larger players in its industry, but the low prices might not last for long. Technical analysis shows an enormous breakout could be in the cards, and early movers could see huge profits. [Get the Ticker Symbol and an In-Depth Analysis Here]( Premarket Highlights 🔎 📈 Yields Tick Higher. The yield on the US ten-year Treasury bond are up 66 basis points over the past 24 hours, and they're currently hovering around 3.887% heading into today's session. What to Watch Today 👀 Investors Brace for More Rate Hikes Stronger-than-expected economic data combined with stubborn inflation have made additional rate hikes a practical certainty. Investors are going to have to accept the reality that rate hikes aren't going anywhere, anytime soon. At least two Fed officials have said publicly that they would've supported higher increases last month. Tomorrow's Fed Minutes could provide more background for investors, but I expect the central bank's tone to remain hawkish for the foreseeable future. Major Earnings 💰 Walmart Inc. [WMT] ... AM Home Depot, Inc. (The) [HD] ... AM Medtronic Plc. [MDT] ... AM Public Service Enterprise Group Incorporated [PEG] ... AM Public Storage Reit [PSA] ... PM Palo Alto Networks, Inc. [PANW] ... PM Realty Income Corporation Reit [O] ... PM Keysight Technologies Inc. [KEYS] ... PM Costar Group, Inc. [CSGP] ... PM Sba Communications Corporation Reit [SBAC] ... PM Economy 🏗 - S&P flash U.S. services PMI [Feb] ... 9:45a - S&P flash U.S. manufacturing PMI [Feb] ... 9:45a - Existing home sales [Jan] ... 10:00a Running Hot 🔥 Gainers - Arbe Robotics [ARBE] >> +73.3% - Lanzatech Global [LNZA] >> +15.1% - Sentage Holdings [SNTG] >> +13.9% Decliners - CVRx [CVRX] >> (30.2%) - Movella Holdings [MVLA] >> (18.7%) - Verrica Pharma ADR [VRCA] >> (13.6%) Sigma Lithium [SGML] - Last Close: $29.48 Reports of a major acquisition are lifting shares of Sigma Lithium. Over the long weekend, Bloomberg reported that Elon Musk's Tesla Motors [TSLA] was considering acquiring the Canada-based battery metal miner. According to the report, Tesla is working with advisers on a bid, but it is just one of the many mining options the company is exploring. Neither Tesla or Sigma Lithium have responded to media requests for comments as of yet. SGML is one of today's top performers with a 25.5% gain on the rumors. My Take: This might be a 'buy the rumor' opportunity, but a good portion of the stock's potential gains may already be priced in. Plus, SGML could see significant downside if a deal doesn't materialize. Chemomab Therapeutics [CMMB] - Last Close: $1.96 Chemomab is taking off on a promising regulatory update. Today, the Israeli biotech firm announced the U.S. Food & Drug Administration cleared its investigational new drug application to evaluate CM-101. The approval clears the way for a Phase 2 trial of CM-101 in adults with systemic sclerosis, or SSc. Chemomab's Chief Medical Officer called the decision an "important milestone for Chemomab." CMMB is up 26.0% on news of the FDA green light, and shares are trading actively in the premarket. My Take: CMMB has been in a bit of a funk lately, but today's rally might help it get its groove back. Shares are currently trading above a key resistance level at $2.30. Owlet [OWLT] - Last Close: $0.3408 Owlet just completed a key fundraising round. On Friday, the infant monitoring tech company announced a private placement of preferred stock and warrants for gross proceeds of $30 million. Owlet said the private placement included certain institutional and other accredited investors, and it closed on Feb. 17th. To complete the offering, Owlet issued Series A preferred stock that is convertible into approximately 61.2 million shares of common stock, plus warrants. Owlet said additional details about the offering can be found in its next Form 8-K filing. News of the private placement sent OWLT rallying, and shares are up 34.9% on elevated trading volume ahead of today's opening bell. My Take: OWLT has performed poorly over the past 12 months, but today's rally could help it get back on track. The private placement is a sign that the smart money sees opportunity here, so this stock might be worth watching. Troika Medical Group [TRKA] - Last Close: $0.2201 Troika Medical is up after reversing an unpopular decision. Late Friday, the professional services company filed to cancel a previously announced registered offering of its shares. Troika filed the original registration statement on April 4th, 2022, but it's canceled as of Friday's filing. The company said it is no longer wishing to pursue a public offering of its securities at this time. News of the canceled offering sent TRKA to a 42.7% gain in today's premarket, and it's this morning's most actively-traded stock. My Take: TRKA probably canceled the offering because of poor market conditions. However, share prices are trending higher, and today's rally could put it above a key resistance point at $0.25. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.